After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Despite government pressure, Twitter did not take action on some handles, why did it do this
On the orders of the central government, Twitter has blocked many accounts in the last about 10 d
The content creator and actor Bhuvan Bam is ready to create a stir among the audience once again
Corona cases are increasing in the country. The worst situation is that of Maharashtra. On Friday
Defense Minister Rajnath Singh's statement has come to the fore regarding the confrontation betwe
Fans were eagerly waiting for Surya's film Kanguva. Today this wait is over. Kanguva has been rel
A tragic accident happened in the Thanjavur district of Tamil Nadu. During the Rath Yatra of the
JEE Main 2022 Application Date Extends: The National Testing Agency (NTA) has extended the applic
The success of Gautam Adani, the world's fourth richest businessman, continues. They are making t
There is a lot of movement in Varanasi of Uttar Pradesh these days. The survey of the Archaeologi
Inflation hit: After Uber, Ola increased the fare, knowing how expensive the journey will be
In the country, from the road to the kitchen, the price of inflation is falling hard on the commo
